BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HS-10390 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HS-10390\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07555054-931@assetmemo.bio
DTSTAMP:20261121T005634Z
DTSTART;VALUE=DATE:20271111
DTEND;VALUE=DATE:20271112
SUMMARY:HS-10390: Phase 2 readout est. (NCT07555054)
DESCRIPTION:HS-10390\, phase 2\, Chronic Kidney Disease.\nStudy: A Study of
  the Effect and Safety of HS-10390 in the Treatment of Participants With C
 hronic Kidney Disease\nEstimated primary completion: 11 November 2027. Thi
 s is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it
  can move.\nDrug page: https://assetmemo.bio/drug/hs-10390#upcoming-events
 \nRegistry record: https://clinicaltrials.gov/study/NCT07555054
URL:https://assetmemo.bio/drug/hs-10390#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
